Literature DB >> 11694509

Crystal structures of the semireduced and inhibitor-bound forms of cyclic nucleotide phosphodiesterase from Arabidopsis thaliana.

Andreas Hofmann1, Melissa Grella, Istvan Botos, Witold Filipowicz, Alexander Wlodawer.   

Abstract

The crystal structure of the semireduced form of cyclic nucleotide phosphodiesterase (CPDase) from Arabidopsis thaliana has been solved by molecular replacement and refined at the resolution of 1.8 A. We have previously reported the crystal structure of the native form of this enzyme, whose main target is ADP-ribose 1",2"-cyclic phosphate, a product of the tRNA splicing reaction. CPDase possesses six cysteine residues, four of which are involved in forming two intra-molecular disulfide bridges. One of these bridges, between Cys-104 and Cys-110, is opened in the semireduced CPDase, whereas the other remains intact. This change of the redox state leads to a conformational rearrangement in the loop covering the active site of the protein. While the native structure shows this partially disordered loop in a coil conformation, in the semireduced enzyme the N-terminal lobe of this loop winds up and elongates the preceding alpha-helix. The semireduced state of CPDase also enabled co-crystallization with a putative inhibitor of its enzymatic activity, 2',3'-cyclic uridine vanadate. The ligand is bound within the active site, and the mode of binding is in agreement with the previously proposed enzymatic mechanism. Selected biophysical properties of the oxidized and the semireduced CPDase are also discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11694509     DOI: 10.1074/jbc.M107889200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  The structure of Pyrococcus horikoshii 2'-5' RNA ligase at 1.94 A resolution reveals a possible open form with a wider active-site cleft.

Authors:  Yong-Gui Gao; Min Yao; Ayuko Okada; Isao Tanaka
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-11-30

2.  AKAP18 contains a phosphoesterase domain that binds AMP.

Authors:  Matthew G Gold; F Donelson Smith; John D Scott; David Barford
Journal:  J Mol Biol       Date:  2007-11-22       Impact factor: 5.469

3.  Conformational changes in redox pairs of protein structures.

Authors:  Samuel W Fan; Richard A George; Naomi L Haworth; Lina L Feng; Jason Y Liu; Merridee A Wouters
Journal:  Protein Sci       Date:  2009-08       Impact factor: 6.725

4.  Mammalian 2',3' cyclic nucleotide phosphodiesterase (CNP) can function as a tRNA splicing enzyme in vivo.

Authors:  Beate Schwer; Anna Aronova; Alejandro Ramirez; Peter Braun; Stewart Shuman
Journal:  RNA       Date:  2007-12-19       Impact factor: 4.942

5.  Structure-function analysis of the kinase-CPD domain of yeast tRNA ligase (Trl1) and requirements for complementation of tRNA splicing by a plant Trl1 homolog.

Authors:  Li Kai Wang; Beate Schwer; Markus Englert; Hildburg Beier; Stewart Shuman
Journal:  Nucleic Acids Res       Date:  2006-01-20       Impact factor: 16.971

6.  Detection of novel members, structure-function analysis and evolutionary classification of the 2H phosphoesterase superfamily.

Authors:  Raja Mazumder; Lakshminarayan M Iyer; Sona Vasudevan; L Aravind
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

7.  Structure and mechanism of E. coli RNA 2',3'-cyclic phosphodiesterase.

Authors:  Barbara S Remus; Agata Jacewicz; Stewart Shuman
Journal:  RNA       Date:  2014-09-19       Impact factor: 4.942

8.  Crystal structure of the C-terminal 2',5'-phosphodiesterase domain of group A rotavirus protein VP3.

Authors:  Tobias Brandmann; Martin Jinek
Journal:  Proteins       Date:  2015-03-25

9.  Structural basis for the evolution of cyclic phosphodiesterase activity in the U6 snRNA exoribonuclease Usb1.

Authors:  Yuichiro Nomura; Eric J Montemayor; Johanna M Virta; Samuel M Hayes; Samuel E Butcher
Journal:  Nucleic Acids Res       Date:  2020-02-20       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.